Core Viewpoint - The article emphasizes the significance of technological innovation in the cosmetics industry, particularly through the development of the "Snow Lotus (SAUSSUREA INVOLUCRATA) callus extract" by YNIFANG, marking a milestone in sustainable resource utilization and modern biotechnology in Chinese beauty brands [3][5][39]. Group 1: Innovation and Development - The new ingredient is a result of deep insights into the unique active components of Snow Lotus and the challenges of traditional raw materials regarding sustainability and stability [5][10]. - YNIFANG's strategic shift from resource dependency to technological creation is highlighted, showcasing its commitment to integrating biotechnology with rare Eastern ingredients [5][39]. - The successful registration of this new ingredient enhances YNIFANG's brand with a strong technological foundation, supporting its "Eastern Skin Formula" [5][39]. Group 2: Research and Insights - YNIFANG has built a dedicated database focusing on the characteristics of Eastern women's skin, conducting extensive research over 19 years, including 67,116 hours of research and 135 offline communication sessions [8]. - The brand identified six core characteristics of Eastern skin, such as higher sensitivity and moisture loss, which informed the development of the Snow Lotus extract [8][10]. Group 3: Ingredient Properties and Benefits - The Snow Lotus callus extract focuses on multiple core functions: antioxidant, soothing, and repairing, effectively addressing issues like pigmentation and high moisture loss in Eastern skin [10][34]. - The extract contains rich active components such as flavonoids, polysaccharides, and phenols, which contribute to its skincare potential [13][34]. Group 4: Technological Advancements - YNIFANG employs innovative techniques like plant stem cell culture and constant temperature extraction to ensure sustainable and high-quality production of the Snow Lotus extract [16][18]. - The extraction process uses pure water as the only solvent, eliminating chemical residue risks and preserving the bioactivity of the active components [19][34]. Group 5: Quality Control and Validation - A comprehensive quality control system is established, ensuring active ingredient content meets strict standards, including flavonoids ≥ 15.0% and polysaccharides ≥ 15.0% [20][34]. - The efficacy of the Snow Lotus extract is validated through a three-tier verification system involving in vitro cell experiments, zebrafish tests, and human clinical trials, confirming its antioxidant and skin repair properties [21][30][32]. Group 6: Market Positioning and Product Development - The new ingredient is targeted at the 25-35 age group, addressing common skin concerns such as dullness and pigmentation through various product lines, including creams and serums [15][36]. - This development complements YNIFANG's existing product offerings, enhancing its competitive edge in the Eastern skincare market [37][39].

Core Viewpoint - The article highlights the significant advancements made by the Chinese beauty brand, Shangmei Co., in the field of peptide skincare technology, particularly through the launch of the "2025 Han Shu Peptide Research and Efficacy Skincare Application Yearbook" which showcases China's innovative capabilities on an international stage [3][5][23]. Group 1: Event Highlights - The "2025 Han Shu Peptide Research and Efficacy Skincare Application Yearbook" was a key highlight at the CAME conference, receiving high praise from industry leaders [5][6]. - The yearbook consolidates over 50 years of global peptide technology development and focuses on China's recent breakthroughs, particularly the环六肽-9 [15][22]. - Shangmei Co. was recognized for its research on环六肽-9, which was included in the "2025 Top Ten Technological Advances in the Chinese Cosmetics Industry" [8][11]. Group 2: Research and Development Achievements - The research on环六肽-9 involved a multidisciplinary approach, utilizing a trillion-level peptide entity library for screening and computational simulation, leading to the development of a proprietary liquid-phase cyclic synthesis technology [11][12]. - The yearbook serves as a practical guide for the application of peptide technology in cosmetics, showcasing the innovative paths and experiences of Chinese brands in this field [15][23]. - Shangmei Co. has established a strong association with the peptide concept, becoming a leading brand in the peptide skincare sector through extensive research and collaboration with domestic and international institutions [25][27]. Group 3: Global Recognition and Future Directions - The participation of Shangmei Co. in major international conferences like EADV and IFSCC marks a significant step for Chinese beauty brands in entering the global scientific community [12][18]. - The collaboration with Dr. Karl Lintner, a recognized expert in peptide technology, further validates Shangmei Co.'s innovative approach and commitment to advancing peptide research [19][20]. - The yearbook is seen as a declaration of China's shift from "manufacturing" to "intelligent manufacturing" in the beauty industry, emphasizing the brand's capability to compete on a global scale [23][28].

Core Viewpoint - The Chinese beauty industry is undergoing a deep upgrade driven by technology and consumer demand, with pharmaceutical companies emerging as key players due to their strong R&D capabilities and quality systems [3][4]. Industry Overview - Over 400 pharmaceutical companies in China are venturing into the cosmetics sector, aiming to transform pharmaceutical technology into effective skincare and health aesthetic products [3]. - The market for cosmetics in China reached approximately 1,073.82 billion yuan in 2024, continuing to exceed the trillion yuan mark for two consecutive years [8]. Company Profile: Zhejiang Haizheng Pharmaceutical Co., Ltd. - Established in 1956, Haizheng Pharmaceutical has a long history in chemical and pharmaceutical production, with a diversified business matrix focusing on various therapeutic areas [5][6]. - The company reported a revenue of 9.787 billion yuan and a net profit of 600 million yuan in 2024, with R&D investment reaching 420 million yuan [6]. Strategic Moves - Haizheng Pharmaceutical is actively engaging in the "pharmaceutical + aesthetics" trend, leveraging its industrial strength and R&D foundation to innovate in synthetic biology and health aesthetic products [4][9]. - The establishment of Haizheng Weilan and Luan Sheng Synthetic Biology marks the company's strategic entry into health aesthetics and synthetic biology, respectively [9][13]. Product Development and Innovation - Luan Sheng Synthetic Biology has developed over 30 raw material varieties, focusing on high-tech and high-value products to avoid low-level price competition [13][14]. - The company plans to create a product pyramid structure, including "road lamp products" for quick commercialization and "lighthouse products" for mid-term development [14]. Market Strategy - Haizheng Weilan aims to build a comprehensive health aesthetic platform, integrating pharmaceutical e-commerce and innovative business models [15][16]. - The company is focusing on nutrition, functional skincare, and medical beauty, utilizing its raw material advantages to develop products that address joint health and liver protection [18]. Future Outlook - The ultimate goal for Haizheng Pharmaceutical is to establish a complete value chain from synthetic biology raw material innovation to health aesthetic brand products, ensuring each link maintains pharmaceutical-grade quality [21][22]. - The company emphasizes a long-term approach to development, prioritizing solid R&D and reliable quality over quick market gains [22].

Core Viewpoint - The Chinese beauty market is increasingly focused on efficacy, with "global first" and "exclusive formulas" becoming key marketing strategies. However, some companies are choosing to invest in fundamental ingredients and systematic research to build competitive barriers, thereby injecting vitality into the industry through solid foundational research and technology transformation [3][6][34]. Group 1: Market Trends and Consumer Demand - The facial cleansing segment is recognized as a high-growth area in the mature beauty market, with total transaction value reaching 21.6 billion yuan from January to August this year, reflecting a 13% year-on-year growth and a 21% increase in transaction volume [6]. - Consumer demand is evolving from basic cleansing functions to multi-dimensional needs such as "sensitive skin-friendly, oil control, acne treatment, and environmental sustainability" [6][34]. Group 2: Kao's Research and Development - Kao Group has introduced three major amino acid cleansing technologies, emphasizing the concept of "skin-source amino acids" inspired by natural moisturizing factors (NMF) in the skin [6][12]. - The first technology, the coconut fatty acid glycine liquid crystal control technology, allows for stable, high-efficiency cleansing formulations without sacrificing skin gentleness and moisturizing properties [8][11]. - The second technology incorporates volcanic mud into the amino acid liquid crystal system, achieving effective oil absorption while maintaining low irritation [10][11]. - The third technology, amino acid cleansing oil micro-emulsification technology (AGCE), enables high-efficiency cleansing without friction, enhancing biodegradability and environmental friendliness [10][11]. Group 3: Kao's Market Position and Strategy - Kao's brand, Fuli Fangsi, has established itself as a leader in the facial cleansing category, ranking No. 1 in sales on major e-commerce platforms in 2024 [26]. - The company has localized its operations in China, enhancing its ability to respond to market changes and consumer needs, which has led to a 30% increase in development speed [26][28]. - Kao's focus on amino acids as a core ingredient reflects its commitment to deep research and the development of a comprehensive "amino acid skincare ecosystem" [22][30]. Group 4: Future Directions and Innovations - Kao plans to continue exploring the potential of amino acids, aiming to develop a family of products centered around "skin-source amino acids" [22][30]. - The company emphasizes the importance of understanding consumer needs and adapting its product offerings accordingly, as seen in the successful launch of products tailored to the preferences of younger consumers [30][32]. - Kao's approach to innovation is rooted in a commitment to scientific research and practical application, ensuring that its products deliver real benefits to consumers [33][34].

Core Viewpoint - The article emphasizes the deep connection between the Chinese beauty brand Chando and the Himalayas, highlighting the brand's commitment to sustainability and biodiversity conservation through its "Himalayan Biodiversity Protection Project" launched in 2025 [4][11]. Group 1: Brand Development and Strategy - Chando's relationship with the Himalayas began with its exploration of "Eastern beauty," which has now become an integral part of its brand DNA [5]. - In 2010, Chando showcased its "Snowy Region Series" at the Shanghai Expo, marking the brand's strategic direction towards utilizing Himalayan resources [6]. - The brand has continuously explored the skincare potential of rare plants from the Himalayas, such as snow lotus and snow ginseng, transforming these natural gifts into effective products [6][10]. Group 2: Environmental and Community Initiatives - Since 2016, Chando has partnered with the China Environmental Protection Foundation to launch the "Chando Himalayan Environmental Protection Fund," successfully restoring 666,000 square meters of grassland and generating nearly 795,000 yuan in economic benefits for local communities [9]. - In 2018, Chando signed a cooperation agreement with the Linzhi municipal government to establish a comprehensive project that includes a research center and a public plant garden, marking a shift towards protective development of wild resources [9][10]. - The brand's initiatives have evolved from resource extraction to protective development, ensuring the preservation of the Himalayan ecosystem [9][10]. Group 3: Scientific and Educational Efforts - Chando's Himalayan Science Popularization Micro-Exhibition Hall serves as a bridge connecting the public with the ecological value of Himalayan resources [12]. - A biodiversity survey conducted at Sejila Mountain allowed participants to experience the richness and fragility of the Himalayan ecosystem firsthand, contributing to a shared understanding of ecological protection [14]. - The establishment of Chando's beauty space in Zhashigang village not only provides beauty services but also creates job opportunities and supports local education initiatives [15]. Group 4: Corporate Responsibility and Future Vision - Chando's journey in the Himalayas exemplifies a company's progression from economic responsibility to charitable responsibility, reflecting a commitment to ethical practices and community engagement [20]. - The brand's unique approach to sustainability positions it as a model for the beauty industry, demonstrating that commercial and social values can mutually reinforce each other [23]. - Chando's upcoming biodiversity protection project signifies a long-term commitment to enhancing the resilience of the Himalayan ecosystem through scientific protection and community empowerment [24][25].

Core Viewpoint - The article discusses the integration of effective skincare and medical aesthetics, highlighting the shift in consumer demand from visible results to verifiable and reproducible outcomes. The emergence of recombinant collagen as a "super ingredient" is noted, with retail scale surpassing 28.6 billion yuan, while the industry faces challenges of unregulated efficacy claims and inconsistent perioperative care standards [2][13]. Summary by Sections Standards and Guidelines - The first domestic standard for recombinant collagen penetration, titled "Detection of Penetration, Degradation, and Promotion of Collagen by Raman Spectroscopy in Humans," was released on September 5, 2025, with Furuida Bio Co., Ltd. as the main drafter [5][14]. - This standard addresses the credibility of ingredient efficacy and clinical care standardization, providing a technical and procedural foundation for the integration of effective skincare and medical aesthetics [3][14]. - The "Medical Aesthetic (Perioperative) Skin Care Guidelines" was also published around the same time, outlining comprehensive skin care protocols from pre-operative to post-operative stages [10][12]. Market Dynamics - The recombinant collagen market has become a core component of effective skincare and medical aesthetics, with a retail scale projected to reach 28.6 billion yuan by 2024, significantly outpacing industry growth rates [13][14]. - The lack of unified standards for product efficacy claims and the inconsistency in perioperative care processes have created a chaotic market environment, indicating a transition from unregulated growth to a more refined approach [13][15]. Furuida Bio's Role - Furuida Bio Co., Ltd. has positioned itself as a leader in the industry by establishing these standards, filling the gap of "no evidence for testing and no benchmarks for evaluation" in the recombinant collagen sector [3][16]. - The company’s strategy involves embedding its products into standardized clinical processes through the "Care Guidelines," while also leveraging the "Detection Standard" to gain consumer trust [16][24]. Brand Development - The high-end medical aesthetic brand "Key C" under Furuida is rapidly gaining market traction, utilizing a "standard + technology + platform" strategy to penetrate the market [17][24]. - Key C has developed a unique "Recombinant Membrane Penetration Engine" that significantly enhances the skin penetration rate of collagen, addressing long-standing industry challenges [19][24]. - The brand's flagship product, "Membrane Penetrating Collagen Essence," has achieved remarkable sales, further solidifying its market presence and brand recognition [19][23]. Future Outlook - With the establishment of these standards and the successful launch of Key C products, Furuida aims to create a comprehensive care solution that spans medical aesthetics and health, positioning itself for significant growth in the global beauty market [24].

Core Viewpoint - The 2025 CAME (China Aroma and Cosmetic Industry Annual Conference and Expo) held in Nanjing focused on "Technology, Brand, and Co-prosperity," showcasing over 500 brands and more than 1,000 new products, emphasizing the integration of government, industry, academia, research, and investment [2][5][38]. Group 1: Event Overview - The event featured high-quality, high-standard, and professional exhibitions, attracting leading beauty companies such as L'Oréal, Procter & Gamble, and Unilever, along with top raw material suppliers like BASF and DSM, creating an "all-star" lineup [5][10]. - CAME has evolved into a "core technology release conference" for domestic and international beauty brands and raw material companies, highlighting its significance in the industry [8][10]. Group 2: Technological Innovations - Numerous innovative technological achievements were showcased, with a strong emphasis on "Chinese-style innovation," including Proya's mitochondrial anti-aging technology and Shiseido's research on the hidden skincare benefits of fermented natto bacteria [10][11][17]. - Shanghai Jahwa introduced the industry's first non-invasive skin glycation quantification and imaging device, filling a gap in the cosmetic field [12]. Group 3: Industry Trends - The event highlighted a shift in the cosmetics industry from "scale expansion" to "value enhancement," with raw material innovation becoming a strategic pivot for this transformation [23][38]. - The demand for diverse consumer needs is pushing upstream supply chain companies to continuously innovate in technology research and scientific communication [23][26]. Group 4: Collaboration and Future Outlook - CAME serves as a bridge for collaboration among raw material suppliers, brands, distributors, and technology companies, accelerating technology transfer and commercial cooperation [34][37]. - The conference is viewed as a crucial opportunity for enhancing the global competitiveness of domestic brands, with a focus on high-quality innovation and development [38].

Core Viewpoint - The 2025 China Fragrance, Flavor, and Cosmetic Industry Annual Conference (2025 CAME) emphasizes the importance of technological innovation, brand value reconstruction, and collaborative ecosystem building in the Chinese cosmetics industry amidst a slowing global market and increasing competition [2][4][6]. Group 1: Technological Innovation - Technological innovation is now a core capability for sustainable development in the industry, moving beyond mere marketing labels [6][18]. - The focus on "self-controllable" raw materials is emerging, with companies like Huaxi Biological achieving breakthroughs in active ingredients that were previously heavily imported [6][7]. - Data-driven and interdisciplinary approaches are becoming new engines for research and development, as seen in the practices of companies like Yunnan Betaini [9][11]. Group 2: Brand Value Reconstruction - Brand value is increasingly tied to reliable product efficacy, with companies like Procter & Gamble emphasizing the importance of collaborative growth rather than zero-sum competition [21][22]. - Cultural empowerment is being leveraged to create differentiated "mind assets," as demonstrated by brands like Baique Ling, which integrates traditional Chinese aesthetics into their products [23][25]. - The revitalization of century-old brands and their internationalization efforts reflect a strategic shift towards expanding brand boundaries [27][30]. Group 3: Collaborative Ecosystem Building - The conference highlighted the need for an open, collaborative, and responsible industry ecosystem to achieve long-term high-quality development [32][38]. - ESG (Environmental, Social, and Governance) principles are being integrated into core business strategies, with leading companies showcasing sustainable practices [34][36]. - The establishment of innovation platforms and collaborative projects between academia and industry aims to bridge the gap between research and market application [34][37]. Group 4: Industry Development and Globalization - The CAME serves as a platform for global resource integration, providing comprehensive support for companies looking to expand internationally [40]. - The conference promotes a consensus on the importance of technology-driven foundations, value co-creation, and ecosystem collaboration to address systemic risks [40][41]. - The ongoing efforts aim to transition China from a "cosmetic manufacturing power" to a "cosmetic strong power," contributing to the global market with Chinese wisdom and solutions [40].

Core Viewpoint - Oushiman is leveraging its 58 years of expertise in pearl technology to establish itself as a leader in the beauty industry, focusing on scientific validation and innovative research to enhance its product efficacy and market competitiveness [3][10][30]. Group 1: Historical Context and Brand Evolution - Oushiman has centered its brand identity around pearls, symbolizing elegance and purity, and has transformed pearl research into a significant technological asset over the past 58 years [3][7]. - The company has achieved the status of the leading domestic brand in whitening skincare products in China, attributed to its proprietary pearl ingredient "Zhenbaiyin Pro" [3][32]. - Oushiman's journey includes three significant phases: from pearl cultivation to active ingredient extraction, and finally to modern scientific innovation and a mature research system [22][25]. Group 2: Research and Development Innovations - The "Zhenbaiyin Pro" ingredient has demonstrated breakthroughs in whitening efficacy, targeting multiple pathways in melanin production and showing superior performance compared to traditional whitening agents [11][13]. - Oushiman has established a comprehensive research framework, including collaborations with global leaders in microbiome and fermentation technology, to explore new skincare solutions [18][27]. - The company has published 58 research papers and holds 159 national patents, showcasing its commitment to scientific advancement in the beauty sector [25][26]. Group 3: Product Development and Market Strategy - The introduction of the "Day White Night Anti-Aging" skincare concept addresses dual consumer concerns of whitening and skin firmness, offering a systematic approach to skincare [34][35]. - The newly launched "Platinum Next Drop" product has shown significant results in skin barrier repair and whitening efficacy, with a reported 50% improvement in skin brightness after 28 days of use [38][40]. - Oushiman's marketing strategy emphasizes the transformation of scientific research into marketable products, reinforcing its position as a competitive player in the beauty industry [32][41].

Core Viewpoint - The establishment of the Xiamen University-Guyu Biomedicine Joint Research Center and the launch of the human-like exosome HME represent a significant breakthrough in the application of exosomes in the beauty industry, potentially overcoming the challenges of industrialization and safety [3][4][5]. Group 1: Understanding Exosomes - Exosomes are small vesicles that facilitate intercellular communication by delivering proteins and nucleic acids, playing a crucial role in regulating metabolism and cellular repair [5][6]. - The decline in the function of exosomes with aging highlights their importance in anti-aging treatments, as they are essential for maintaining healthy cellular communication [6][8]. Group 2: Challenges in Application - Current market offerings primarily feature plant-derived exosomes, which are less effective due to structural differences with human cells, while human-derived exosomes face regulatory challenges and safety concerns [8][10]. - The classification of exosomes as Advanced Therapy Medicinal Products (ATMP) by the Chinese National Medical Products Administration indicates a clearer direction for research and application in the industry [8][10]. Group 3: Breakthrough of HME - The human-like exosome HME is not a simple extraction from natural exosomes but a product of reverse engineering and optimization, addressing safety, efficiency, and industrialization challenges [10][12]. - HME mimics the structure and active components of human-derived exosomes, allowing for better cellular recognition and uptake, thus enhancing delivery efficiency [12][13]. Group 4: Advantages of HME - HME directly regulates target genes and signaling pathways, significantly shortening the action mechanism compared to traditional anti-aging ingredients [16]. - The incorporation of targeting peptides in HME allows for precise delivery to key skin cells responsible for regeneration, improving utilization compared to conventional treatments [16][17]. - HME can be stored at room temperature, overcoming the stability issues associated with natural exosomes, thus facilitating large-scale production [17][18]. Group 5: Research and Development Strategy - The collaboration with Xiamen University enhances Guyu's research capabilities, shifting focus from application optimization to foundational research in anti-aging [22][23]. - The development of rare ginsenoside CK for anti-aging drug research reflects a strategic move to strengthen the brand's capabilities in raw material selection and efficacy validation [23][24]. Group 6: Future Directions - The introduction of HME signifies a transition towards gene-level research in skincare, aiming to directly influence cellular functions and reverse aging processes [25][26]. - Guyu's approach aligns with the broader goals of life sciences, positioning the brand uniquely in the competitive landscape of global beauty technology [25][26].